FEBS Letters · 1975 · 316 citations · 7 references
MedicineBiochemistryOncologyCellular MetabolismMetabolismNeoplasiaCancer MetabolismHepatic MetabolismLiver CancerMalignant NeoplasmsMetabolic ReprogrammingMetabolic Reprogramming In CancerGlutamine MetabolismHepatic Enzyme AlterationsImbalanceMetabolic Alterations In CancerNeoplastic DiseaseNeoplastic ProgressionTumor MetabolismXanthine Oxidoreductase Metabolism
Xanthine oxidase was decreased 2- to 10-fold in all examined rat hepatomas irrespective of the malignancy; growth rate and degrees of histological differentiation of the neoplasms. The affinity to substrate (KM=6-8 muM) and the pH optimum (8.0) of the liver and hepatoma enzymes were the same. The reprogramming of gene expression, as manifested in the decreased activity of this key purine metabolizing enzyme, appears to be specific to neoplastic transformation. Since glutamine PRPP amidotransferase activity was increased but the opposing enzyme, xanthine oxidase, was decreased in all the hepatomas, the reprogramming of gene expression results in an imbalance that favors synthesis against catabolism. This enzymatic imbalance should confer selective advantages to the cancer cells.
7
H. Busch · The American Journal of the Medical Sciences · 1969 · 1.2K citations
Medicine, Cancer Biology, Oncology +12
Chemistry of Enzymes in Cancer
Postgraduate Medical Journal · 1961 · 27 citations · Full text
Chemistry of Enzymes in Cancer
The Medical Journal of Australia · 1962 · 22 citations · Full text